vs

Side-by-side financial comparison of Cryoport, Inc. (CYRX) and LandBridge Co LLC (LB). Click either name above to swap in a different company.

LandBridge Co LLC is the larger business by last-quarter revenue ($56.8M vs $45.5M, roughly 1.2× Cryoport, Inc.). LandBridge Co LLC runs the higher net margin — 14.2% vs -17.5%, a 31.7% gap on every dollar of revenue. On growth, LandBridge Co LLC posted the faster year-over-year revenue change (55.6% vs 9.6%). LandBridge Co LLC produced more free cash flow last quarter ($122.0M vs $-4.5M). Over the past eight quarters, LandBridge Co LLC's revenue compounded faster (72.8% CAGR vs 10.4%).

Cryoport, Inc. is a global provider of specialized temperature-controlled logistics and supply chain solutions focused on the life sciences, biopharmaceutical, and cell and gene therapy sectors. It partners with research institutions, biotech firms, and pharmaceutical manufacturers globally to support the safe transport of sensitive biological materials including clinical trial samples and advanced therapy products.

CYRX vs LB — Head-to-Head

Bigger by revenue
LB
LB
1.2× larger
LB
$56.8M
$45.5M
CYRX
Growing faster (revenue YoY)
LB
LB
+45.9% gap
LB
55.6%
9.6%
CYRX
Higher net margin
LB
LB
31.7% more per $
LB
14.2%
-17.5%
CYRX
More free cash flow
LB
LB
$126.6M more FCF
LB
$122.0M
$-4.5M
CYRX
Faster 2-yr revenue CAGR
LB
LB
Annualised
LB
72.8%
10.4%
CYRX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CYRX
CYRX
LB
LB
Revenue
$45.5M
$56.8M
Net Profit
$-8.0M
$8.1M
Gross Margin
47.8%
Operating Margin
-17.0%
60.0%
Net Margin
-17.5%
14.2%
Revenue YoY
9.6%
55.6%
Net Profit YoY
57.4%
-83.7%
EPS (diluted)
$-0.19
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CYRX
CYRX
LB
LB
Q4 25
$45.5M
$56.8M
Q3 25
$44.2M
$50.8M
Q2 25
$45.5M
$47.5M
Q1 25
$41.0M
$44.0M
Q4 24
$41.5M
$36.5M
Q3 24
$38.3M
$28.5M
Q2 24
$39.7M
$26.0M
Q1 24
$37.3M
$19.0M
Net Profit
CYRX
CYRX
LB
LB
Q4 25
$-8.0M
$8.1M
Q3 25
$-6.9M
$8.1M
Q2 25
$105.2M
$7.5M
Q1 25
$-12.0M
$6.5M
Q4 24
$-18.7M
$49.3M
Q3 24
$805.0K
$2.7M
Q2 24
$-78.0M
$-57.7M
Q1 24
$-18.9M
$10.8M
Gross Margin
CYRX
CYRX
LB
LB
Q4 25
47.8%
Q3 25
48.2%
Q2 25
47.0%
Q1 25
45.4%
Q4 24
47.0%
Q3 24
45.5%
Q2 24
44.5%
Q1 24
40.4%
Operating Margin
CYRX
CYRX
LB
LB
Q4 25
-17.0%
60.0%
Q3 25
-22.5%
60.8%
Q2 25
-21.2%
60.0%
Q1 25
-23.1%
57.0%
Q4 24
-30.7%
49.4%
Q3 24
-34.9%
11.2%
Q2 24
-196.5%
-197.4%
Q1 24
-46.9%
71.1%
Net Margin
CYRX
CYRX
LB
LB
Q4 25
-17.5%
14.2%
Q3 25
-15.7%
15.9%
Q2 25
231.4%
15.8%
Q1 25
-29.2%
14.7%
Q4 24
-45.1%
135.2%
Q3 24
2.1%
9.3%
Q2 24
-196.4%
-222.1%
Q1 24
-50.7%
56.7%
EPS (diluted)
CYRX
CYRX
LB
LB
Q4 25
$-0.19
$0.24
Q3 25
$-0.18
$0.26
Q2 25
$2.05
$0.24
Q1 25
$-0.28
$0.20
Q4 24
$-0.42
Q3 24
$-0.02
$-0.04
Q2 24
$-1.62
Q1 24
$-0.43

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CYRX
CYRX
LB
LB
Cash + ST InvestmentsLiquidity on hand
$411.2M
$30.7M
Total DebtLower is stronger
$570.7M
Stockholders' EquityBook value
$502.6M
$340.3M
Total Assets
$765.0M
$1.4B
Debt / EquityLower = less leverage
1.68×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CYRX
CYRX
LB
LB
Q4 25
$411.2M
$30.7M
Q3 25
$421.3M
$28.3M
Q2 25
$426.0M
$20.3M
Q1 25
$244.0M
$14.9M
Q4 24
$250.6M
$37.0M
Q3 24
$259.4M
$14.4M
Q2 24
$414.9M
$24.6M
Q1 24
$438.2M
Total Debt
CYRX
CYRX
LB
LB
Q4 25
$570.7M
Q3 25
$366.1M
Q2 25
$370.9M
Q1 25
$375.5M
Q4 24
$385.5M
Q3 24
$242.4M
Q2 24
$360.8M
Q1 24
Stockholders' Equity
CYRX
CYRX
LB
LB
Q4 25
$502.6M
$340.3M
Q3 25
$513.3M
$272.0M
Q2 25
$519.1M
$266.4M
Q1 25
$398.8M
$217.0M
Q4 24
$401.9M
$211.8M
Q3 24
$418.6M
$97.2M
Q2 24
$400.1M
$296.4M
Q1 24
$472.2M
$162.3M
Total Assets
CYRX
CYRX
LB
LB
Q4 25
$765.0M
$1.4B
Q3 25
$774.3M
$1.1B
Q2 25
$773.9M
$1.1B
Q1 25
$699.8M
$1.0B
Q4 24
$703.5M
$1.0B
Q3 24
$701.8M
$689.9M
Q2 24
$852.3M
$710.5M
Q1 24
$942.8M
Debt / Equity
CYRX
CYRX
LB
LB
Q4 25
1.68×
Q3 25
1.35×
Q2 25
1.39×
Q1 25
1.73×
Q4 24
1.82×
Q3 24
2.49×
Q2 24
1.22×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CYRX
CYRX
LB
LB
Operating Cash FlowLast quarter
$919.0K
$126.3M
Free Cash FlowOCF − Capex
$-4.5M
$122.0M
FCF MarginFCF / Revenue
-10.0%
214.9%
Capex IntensityCapex / Revenue
12.0%
7.5%
Cash ConversionOCF / Net Profit
15.68×
TTM Free Cash FlowTrailing 4 quarters
$-25.0M
$207.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CYRX
CYRX
LB
LB
Q4 25
$919.0K
$126.3M
Q3 25
$2.2M
$34.9M
Q2 25
$-7.3M
$37.3M
Q1 25
$-4.3M
$15.9M
Q4 24
$-5.5M
$67.6M
Q3 24
$447.0K
$7.5M
Q2 24
$-8.0M
$16.0M
Q1 24
$-3.3M
$17.2M
Free Cash Flow
CYRX
CYRX
LB
LB
Q4 25
$-4.5M
$122.0M
Q3 25
$-1.3M
$33.7M
Q2 25
$-11.7M
$36.1M
Q1 25
$-7.5M
$15.8M
Q4 24
$-10.7M
$66.7M
Q3 24
$-3.8M
$7.1M
Q2 24
$-11.8M
$15.7M
Q1 24
$-7.3M
$17.1M
FCF Margin
CYRX
CYRX
LB
LB
Q4 25
-10.0%
214.9%
Q3 25
-2.9%
66.3%
Q2 25
-25.7%
75.9%
Q1 25
-18.3%
36.0%
Q4 24
-25.8%
182.6%
Q3 24
-9.9%
25.1%
Q2 24
-29.8%
60.4%
Q1 24
-19.5%
90.1%
Capex Intensity
CYRX
CYRX
LB
LB
Q4 25
12.0%
7.5%
Q3 25
7.8%
2.3%
Q2 25
9.6%
2.6%
Q1 25
7.7%
0.2%
Q4 24
12.6%
2.7%
Q3 24
11.1%
1.1%
Q2 24
9.5%
1.4%
Q1 24
10.7%
0.5%
Cash Conversion
CYRX
CYRX
LB
LB
Q4 25
15.68×
Q3 25
4.31×
Q2 25
-0.07×
4.98×
Q1 25
2.46×
Q4 24
1.37×
Q3 24
0.56×
2.80×
Q2 24
Q1 24
1.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons